PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
42 hedge funds and large institutions have $328M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
42
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.61M | |
| 2 | +$4.23M | |
| 3 | +$2.95M | |
| 4 |
Bank of New York Mellon
New York
|
+$2.58M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.93M |
Top Sellers
| 1 | -$6.6M | |
| 2 | -$3.35M | |
| 3 | -$1.59M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.51M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.43M |